LIP
Lighthouse Investment Partners Portfolio holdings
AUM
$2.3B
This Quarter Return
+8.73%
1 Year Return
+18.81%
3 Year Return
+54.09%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$1.37B
(-19%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-29.73%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
440
New
135
Increased
60
Reduced
66
Closed
163
Top Buys
| 1 |
Walmart
WMT
|
$24.9M |
| 2 |
Kraft Heinz
KHC
|
$20M |
| 3 |
Truist Financial
TFC
|
$16.4M |
| 4 |
Kimberly-Clark
KMB
|
$16M |
| 5 |
Target
TGT
|
$14.8M |
Top Sells
| 1 |
Xcel Energy
XEL
|
$32M |
| 2 |
Procter & Gamble
PG
|
$27.5M |
| 3 |
American Electric Power
AEP
|
$22.8M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
$22.5M |
| 5 |
McDonald's
MCD
|
$22.5M |
Sector Composition
| 1 | Real Estate | 24.14% |
| 2 | Consumer Staples | 23.5% |
| 3 | Healthcare | 10.89% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
TG Therapeutics
TGTX
$4.72B
| $1.31M | 0.06% |
+76,729
| New | +$1.31M |
|
202
Xenon Pharmaceuticals
XENE
$3.03B
| $1.28M | 0.06% |
+27,775
| New | +$1.28M |
|
|
AMAM
203
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $1.27M | 0.06% |
+88,925
| New | +$1.27M |
|
204
Everest Group
EG
$14.5B
| $1.25M | 0.06% |
+3,537
| New | +$1.25M |
|
205
Omnicell
OMCL
$1.47B
| $1.23M | 0.06% |
+32,670
| New | +$1.23M |
|
206
iShares China Large-Cap ETF
FXI
$6.71B
| $1.2M | 0.05% |
+50,000
| New | +$1.2M |
|
207
JD.com
JD
$44.8B
| $1.16M | 0.05% |
+40,000
| New | +$1.16M |
|
208
Harley-Davidson
HOG
$3.56B
| $1.13M | 0.05% |
+30,746
| New | +$1.13M |
|
209
MoonLake Immunotherapeutics
MLTX
$3.72B
| $1.13M | 0.05% |
+18,728
| New | +$1.13M |
|
210
Syndax Pharmaceuticals
SNDX
$1.39B
| $1.13M | 0.05% |
+52,199
| New | +$1.13M |
|
211
Essex Property Trust
ESS
$16.8B
| $1.12M | 0.05% |
+4,500
| New | +$1.12M |
|
|
BRSL
212
Brightstar Lottery PLC
BRSL
$3.11B
| $1.1M | 0.05% |
+40,000
| New | +$1.1M |
|
213
Ally Financial
ALLY
$12.5B
| $1.09M | 0.05% |
+31,085
| New | +$1.09M |
|
214
Coherus Oncology, Inc. Common Stock
CHRS
$138M
| $1.04M | 0.05% |
+313,134
| New | +$1.04M |
|
|
AMED
215
DELISTED
Amedisys
AMED
| $1.04M | 0.05% |
10,903
-2,594
| -19% | -$247K |
|
|
SWTX
216
DELISTED
SpringWorks Therapeutics
SWTX
| $1.02M | 0.05% |
+28,010
| New | +$1.02M |
|
|
HES
217
DELISTED
Hess
HES
| $999K | 0.05% |
+6,929
| New | +$999K |
|
218
Freeport-McMoran
FCX
$64.5B
| $988K | 0.04% |
23,217
+15,689
| +208% | +$668K |
|
219
Schrodinger
SDGR
$1.41B
| $982K | 0.04% |
+27,425
| New | +$982K |
|
220
Qiagen
QGEN
$10.2B
| $975K | 0.04% |
22,454
-58,775
| -72% | -$2.55M |
|
221
Acadia Healthcare
ACHC
$2.17B
| $960K | 0.04% |
12,351
-67,619
| -85% | -$5.26M |
|
222
Middleby
MIDD
$6.96B
| $937K | 0.04% |
6,370
-3,443
| -35% | -$507K |
|
223
RxSight
RXST
$356M
| $904K | 0.04% |
+22,433
| New | +$904K |
|
|
224
Procter & Gamble
PG
$370B
| $879K | 0.04% |
6,000
-188,000
| -97% | -$27.5M |
|
225
Grifois
GRFS
$6.59B
| $842K | 0.04% |
+72,857
| New | +$842K |
|